Skip to main content
. Author manuscript; available in PMC: 2023 Sep 8.
Published in final edited form as: Circ Arrhythm Electrophysiol. 2022 Sep 8;15(9):e007960. doi: 10.1161/CIRCEP.121.007960

Figure 1. Evaluation of sinus tachycardia.

Figure 1.

AAbs, autoantibodies; ABG, arterial blood gas; ABPM, ambulatory blood pressure monitoring; AF, atrial fibrillation; AFL, atrial flutter; AVNRT, atrioventricular node re-entry tachycardia; AVRT, atrioventricular re-entry tachycardia; BNP, B-type natriuretic peptide; CMR, cardiovascular magnetic resonance; COPD, chronic obstructive pulmonary disease; CPET, cardiopulmonary exercise testing; CRP, C-reactive protein; EAT, ectopic atrial tachycardia; hCG, human chorionic gonadotropin; ILD, interstitial lung disease; IST, inappropriate sinus tachycardia; MCAS, mast cell activation syndrome; LV, left ventricle; PCT, procalcitonin; PFTs, pulmonary function tests; PGD2, prostaglandin D2; POTS, postural orthostatic tachycardia syndrome; RV, right ventricle; SNRT, sinus node re-entry tachycardia; ST, sinus tachycardia; TSH, thyroid-stimulating hormone; VHD, valvular heart disease; WBC, white blood cells; 6MWT, 6-minute walking test.